Nephrology
Nephrology News

Latest Nephrology News

Secondary Hyperparathyroidism Subtotal Parathyroidectomy Safe, Effective, Study Finds

Subtotal Parathyroidectomy Safe, Effective, Study Finds

Researchers highlighted the benefit of iPTH monitoring.

Diabetes Prior CV Event Ups Death Risk in Type 2 Diabetes Patients

Prior CV Event Ups Death Risk in Type 2 Diabetes Patients

Those with type 2 diabetes and heart disease as well as a prior cardiovascular event have an increased risk of cardiovascular mortality.

Chronic Kidney Disease (CKD) Blacks With Diabetes and CKD Have Higher CVD Risk

Blacks With Diabetes and CKD Have Higher CVD Risk

Odds of cardiovascular mortality 14.8% higher in black Americans with both conditions.

Transplantation Worse Re-transplant Outcomes for HIV Positive Patients

Worse Re-transplant Outcomes for HIV Positive Patients

HIV retransplant recipients have increased risk of death and graft loss versus HIV re-KT patients

Secondary Hyperparathyroidism Parathyroidectomy Rates Stable Despite Changes in Medical Therapy

Parathyroidectomy Rates Stable Despite Changes in Medical Therapy

The debate continues on how best to use parathyroidectomy to treat severe SHPT.

Diabetes Safety Profile Varies for Add-On Second-Line Diabetes Drugs

Safety Profile Varies for Add-On Second-Line Diabetes Drugs

For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks.

Chronic Kidney Disease (CKD) Novel Hyperkalemia Drugs May Help Optimize Use of RAAS Inhibitors

Novel Hyperkalemia Drugs May Help Optimize Use of RAAS Inhibitors

High potassium levels associated with the use of renin-angiotensin-aldosterone system inhibitors limit their use in CKD patients.

End-Stage Renal Disease Higher Allopurinol Dose Protects Elderly From Renal Failure

Higher Allopurinol Dose Protects Elderly From Renal Failure

A higher allopurinol dose was protective against renal failure in elderly allopurinol recipients.

Hyperphosphatemia Even High-Normal Phosphorus May Be an ESRD Risk Factor, Study Finds

Even High-Normal Phosphorus May Be an ESRD Risk Factor, Study Finds

Phosphorus targets in patients with chronic kidney disease stage 3 to 4 should be below 4.3 mg/dL, researchers report.

Hyperphosphatemia Young Patients Often Misperceive Adherence to Phosphorus Control

Young Patients Often Misperceive Adherence to Phosphorus Control

Hyperphosphatemia is present in many who say following diets and binder schedules is easy.

Secondary Hyperparathyroidism New Drug Cleared to Treat SHPT in Chronic Kidney Disease Patients

New Drug Cleared to Treat SHPT in Chronic Kidney Disease Patients

Calcifediol formulation is indicated for CKD stage 3 or 4 patients with secondary hyperparathyroidism associated with vitamin D insufficiency.

Lupus Nephritis Lupus Nephritis ESRD Has Worse Outcomes

Lupus Nephritis ESRD Has Worse Outcomes

Researchers find an increased risk of death among patients.

Hyperphosphatemia Patient Autonomy May Improve Phosphate Binder Adherence

Patient Autonomy May Improve Phosphate Binder Adherence

Autonomy support could be an appropriate target for culturally informed strategies to optimize mineral bone health.

Diabetes Long-Acting Opioids May Increase Risk of Premature Death

Long-Acting Opioids May Increase Risk of Premature Death

In a study of patients who had been prescribed long-acting opioid medications, 185 patients in the opioid group died.

Diabetes FDA Strengthens AKI Warning for Some SGLT2 Inhibitors

FDA Strengthens AKI Warning for Some SGLT2 Inhibitors

The Food and Drug Administration (FDA) announced it is strengthening the current warning about the risk of acute kidney injury for drug products containing canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).

Diabetes Slower Kidney Disease Progression Observed With Empagliflozin Use

Slower Kidney Disease Progression Observed With Empagliflozin Use

Incident or worsening nephropathy was observed in 12.7% of patients receiving empagliflozin compared with 18.8% of those receiving placebo.

Diabetes Diabetes Remission From Surgery Cuts Microvascular Disease Risk

Diabetes Remission From Surgery Cuts Microvascular Disease Risk

Length of time spent in remission inversely related to risk of microvascular disease.

Diabetes Liraglutide Cuts CV Events in High-Risk Type 2 Diabetes Patients

Liraglutide Cuts CV Events in High-Risk Type 2 Diabetes Patients

There was also a 22% reduction in the development of renal outcomes with liraglutide compared to placebo.

Hyperphosphatemia Calcium-based Phosphate Binders Linked to Higher Mortality

Calcium-based Phosphate Binders Linked to Higher Mortality

A mortality rate increase of 43 cases per 1000 patients was found for calcium-based phosphate binders.

Chronic Kidney Disease (CKD) Chronic Kidney Disease Impairs Digestive Function

Chronic Kidney Disease Impairs Digestive Function

CKD associated with dysmotility and reduces fasting and post-prandial small bowel water.